A Health Economics study highlights an important public health lesson: a treatment breakthrough can save lives while also changing behavior in ways that require new prevention strategies.
The research looked at the period after highly active antiretroviral therapy, or HAART, became widely available in the late 1990s. HAART transformed HIV care by dramatically improving survival. The study then examined whether that success was followed by changes in syphilis patterns across the United States.
Using Centers for Disease Control data and pharmaceutical sales data, investigators found that states with higher AIDS prevalence experienced larger increases in syphilis after HAART became available. The increases were concentrated among men, while rates among women continued to decline. The pattern suggests that a lower perceived risk of HIV may have influenced sexual behavior and indirectly affected other sexually transmitted infections.
The authors estimated that without HAART, syphilis cases from 1996 through 2008 would have been far lower. That does not reduce the value of HIV treatment. Instead, it shows why lifesaving therapy must be paired with testing, counseling, condom access, PrEP, partner services, and routine screening for other sexually transmitted infections.
For clinicians and public health programs, the message is practical. HIV treatment and viral suppression remain essential, but they should not be treated as a replacement for prevention. As syphilis reaches levels not seen in decades, integrated sexual health care is needed so that progress against HIV does not leave other infections unchecked.